GlassScriptPhysician profile
Dillon Swartz
NPI 1720965056
$526.14
in general payments reported to CMS, 2019-2025
17 companies · $526 in 2025
The $526 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $526.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $526.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $75.35 | 2025 | Dexcom G6 Transmitter |
| Lundbeck LLC | $70.40 | 2025 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $68.00 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $38.15 | 2025 | Rexulti |
| Sumitomo Pharma America, INC. | $34.86 | 2025 | Myfembree |
| Exact Sciences Corporation | $30.79 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Corium, LLC | $25.55 | 2025 | Azstarys |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.28 | 2025 | Xifaxan |
| Axsome Therapeutics, INC. | $24.78 | 2025 | Sunosi |
| Glaxosmithkline, LLC. | $20.14 | 2025 | Trelegy Ellipta |
| Insulet Corporation | $18.70 | 2025 | Omnipod |
| Ardelyx, INC. | $18.00 | 2025 | Ibsrela |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $17.81 | 2025 | Caplyta |
| Merck Sharp & Dohme LLC | $15.78 | 2025 | Verquvo |
| Collegium Pharmaceutical, INC. | $15.25 | 2025 | Jornay Pm |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $13.71 | 2025 | Ozempic |
| Inspire Medical Systems, INC. | $13.59 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dillon Swartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.